BGNE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 00:29):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Stats
今日成交量	60 234
平均成交量	176 533
市值	16.67B
EPS	$-1.850 ( Q1 \| 2024-05-08 )
下一个收益日期	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-19.47 (Sector) 42.63 (Industry) 24.32
ATR14	$0.224 (0.15%)

AADI -3.24%

ABCL 1.56%

ABCM 0.04%

ABEO -2.61%

ABIO -3.73%

ABOS 0.70%

ABSI 2.05%

ABUS -1.80%

ABVX -1.50%

ACAD -0.54%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -4.11%

ACHV -0.22%

ACIU -0.75%

ACLX 0.74%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.01%

ADGI 0.87%

ADIL 1.75%

ADMA -2.16%

ADPT 0.15%

ADTX -2.08%

ADVM -3.33%

ADXN -1.60%

AEON -4.50%

AEZS -2.49%

AFMD -1.60%

AGEN -2.05%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 0.61%

AKRO -3.27%

AKTX 1.05%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.69%

ALGS -0.74%

ALKS 0.48%

ALLK -9.32%

ALLO -6.04%

ALLR -0.63%

ALNA 3.16%

ALNY 2.42%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.19%

ALVR 2.60%

ALXN 0.00%

ALXO -13.23%

ALZN 5.27%

AMRN -0.46%

AMTI -3.13%

ANAB 1.22%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.22%

ANPC -3.15%

APGE -0.08%

APGN 8.48%

APGNW 30.65%

APLM -2.32%

APLS 0.07%

APLT -3.04%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -4.99%

ARDS -14.23%

ARDX 0.08%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.26%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.79%

ARWR -0.67%

ASLN -3.88%

ASMB -5.81%

ASND -1.74%

ATAI -1.85%

ATHA 5.02%

ATHE 0.56%

ATHX -33.50%

ATNF 4.29%

ATOS 1.93%

ATRA -1.93%

ATXI -2.78%

ATXS -0.22%

AUPH -0.90%

AURA 2.79%

AUTL -1.58%

AVBP -1.89%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.45%

AVTX -1.25%

AVXL -3.83%

AXLA 0.00%

AXSM -1.08%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.91%

BCAB 5.56%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.83%

BCRX 0.33%

BCTX 8.90%

BCTXW -16.32%

BCYC 1.10%

BDRX -4.64%

BDTX -1.81%

BEAM 0.95%

BFRA -2.91%

BGNE -2.78%

BIOR -6.15%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE 0.58%

BMEA -10.75%

BMRN 0.05%

BNOX 6.22%

BNTC -0.42%

BNTX -1.64%

BOLD -12.19%

BOLT -0.64%

BPMC -1.11%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 25.92%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.66%

CADL -1.95%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.97%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.67%

CCCC -6.16%

CCXI 0.00%

CDAK 0.00%

CDIO -2.18%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -4.92%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.82%

CDXS 7.24%

CELC -3.94%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.39%

CERO -3.88%

CEROW -21.56%

CFRX -27.95%

CGEM -2.80%

CGEN -3.05%

CGON -1.72%

CGTX -3.98%

CHMA -6.00%

CHRS 1.58%

CINC 0.00%

CING -2.67%

CINGW 34.95%

CKPT -3.81%

CLBS -16.75%

CLDX -1.24%

CLGN 0.34%

CLLS -4.15%

CLNN 0.00%

CLNNW 0.00%

CLRB 6.30%

CLSD -4.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.47%

CNCE 0.00%

CNSP -36.73%

CNST 0.00%

CNTA -0.28%

CNTB 0.00%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -3.42%

CORT 2.73%

COYA -1.46%

CPRX -1.02%

CRBP -3.12%

CRBU -5.97%

CRDF -0.89%

CRGX -0.07%

CRIS -1.72%

CRNX -5.89%

CRSP 0.52%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -4.12%

CTNM -2.11%

CTXR 2.45%

CUE 5.84%

CVAC -5.36%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.13%

CYTO -1.82%

DARE 4.02%

DAWN -1.12%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.38%

DNLI -1.30%

DNTH -10.07%

DOMH 2.43%

DRMA -1.68%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.72%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.61%

EDSA 3.19%

EFTR 5.07%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -6.64%

ELOX -5.38%

ELTX -4.26%

ELVN -4.07%

ELYM 2.23%

ENGN -1.72%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 1.58%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.72%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.37%

ETON 1.82%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.37%

EXAI -1.14%

EXEL -0.02%

EYEG -0.69%

EYEN 1.42%

EYPT 0.36%

FATE -9.95%

FBIO 0.85%

FBIOP -0.37%

FBLG -15.90%

FBRX -0.02%

FDMT -3.41%

FENC -0.97%

FGEN -7.30%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.03%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.43%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -5.86%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.54%

GHRS -2.30%

GLMD -4.13%

GLPG -2.15%

GLSI 1.43%

GLTO -2.16%

GLUE -3.17%

GLYC -10.15%

GMAB -0.39%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX -0.22%

GNPX 1.49%

GNTA 3.94%

GOSS -10.90%

GOVX 1.36%

GOVXW -49.04%

GPCR -8.33%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.48%

GRTX 5.14%

GTHX 0.23%

GUTS -5.08%

GXGXW 41.67%

GYRE -8.82%

HALO -1.35%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.15%

HOOK 2.33%

HOTH -3.51%

HOWL -1.71%

HRMY 1.94%

HRTX 4.10%

HSTO 0.00%

HUMA 0.51%

HUMAW -0.01%

IBRX -4.26%

ICCC 0.22%

ICPT 0.21%

ICU 19.81%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.58%

IFRX -1.54%

IGMS -0.29%

IKNA 0.89%

IKT 0.70%

IMAB 2.33%

IMCR -3.01%

IMGN 0.02%

IMGO 0.00%

IMMP 4.95%

IMMX -7.76%

IMNM 0.74%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.79%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -4.82%

INAB -0.56%

INBX 0.76%

INCY -1.33%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 0.61%

INMB 1.68%

INO -1.31%

INSM -1.48%

INTS -2.75%

INVA 0.53%

INZY 0.69%

IOBT -10.63%

IONS 0.77%

IOVA -2.96%

IPA -0.49%

IPHA 5.58%

IPSC -2.54%

IRON -1.89%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -3.31%

JAGX 1.19%

JANX -3.93%

JAZZ -0.56%

JNCE 0.00%

JSPR -5.84%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.11%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -6.16%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.10%

KRRO -8.11%

KRTX 0.03%

KRYS -0.55%

KTRA 9.22%

KTTA -6.79%

KTTAW 0.92%

KURA -0.29%

KYMR -3.01%

KYTX -4.52%

KZIA 2.65%

KZR -0.85%

LABP 0.57%

LBPH -1.52%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.84%

LENZ -4.30%

LEXX -0.38%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.97%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.39%

LPCN -1.86%

LPTX -2.75%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -2.79%

LXRX -2.34%

LYEL -36.03%

LYRA 1.16%

MACK 0.10%

MBIO -10.02%

MBRX -1.72%

MCRB 3.14%

MDGL -1.14%

MDNA -13.16%

MDWD -0.14%

MDXG -2.80%

MEIP 1.40%

MESO -1.41%

MGNX -2.34%

MGTA -7.74%

MGTX -3.61%

MGX -4.02%

MIRM -1.03%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.56%

MLYS -7.37%

MNKD 0.29%

MNMD -0.07%

MNOV 2.11%

MNPR -8.52%

MOLN 1.79%

MOR 1.20%

MORF -3.22%

MREO -2.71%

MRKR 2.57%

MRNA -5.97%

MRNS -4.40%

MRSN -2.38%

MRTX -0.17%

MRUS 0.23%

MRVI -1.24%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 5.77%

NAMS 3.33%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.41%

NKGN 10.08%

NKGNW 8.00%

NKTR -4.21%

NKTX -5.05%

NLSP 5.91%

NLSPW 26.67%

NMRA -2.86%

NMTR -42.97%

NOVN -24.84%

NRBO 7.28%

NRIX -2.12%

NRSN -5.12%

NRSNW 0.00%

NRXP -3.72%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.42%

NTEC -12.45%

NTHI 0.00%

NTLA -6.75%

NTRBW -31.07%

NUVL -1.58%

NVAX -2.29%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.45%

OABIW -10.06%

OBIO -3.07%

OBSV 0.00%

OCEA 0.00%

OCGN 3.40%

OCS -1.00%

OCUL -0.08%

OCUP 1.84%

ODT -4.27%

OKYO 1.51%

OLMA -5.28%

OMER -1.03%

OMGA 5.63%

ONCO 4.54%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 1.49%

ONTX -0.47%

ONVO 0.47%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.42%

ORMP 18.30%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.22%

OVID 0.40%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.18%

PCSA 0.00%

PCVX -0.30%

PDSB -3.16%

PEPG 0.78%

PGEN -2.70%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.47%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.33%

PLUR 7.39%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -5.53%

PRAX 3.06%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.00%

PRQR -0.66%

PRTA -2.46%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.46%

PSTX -1.36%

PTCT -0.26%

PTE -0.82%

PTGX -0.87%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 0.65%

QLGN -3.00%

QNCX 5.70%

QNRX -1.14%

QSI -11.54%

QSIAW -3.13%

QTTB -3.45%

QURE -0.78%

RAIN -1.63%

RANI 6.42%

RAPT -1.30%

RARE 1.58%

RCKT -8.64%

REGN 0.22%

RENB -3.42%

REPL -2.15%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 4.38%

RGLS -6.78%

RGNX -5.88%

RIGL -3.28%

RLAY -3.86%

RLMD 0.35%

RLYB -1.34%

RNA 0.92%

RNAC -2.94%

RNAZ -1.90%

RNXT 0.89%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.78%

RPRX 0.28%

RPTX 0.15%

RUBY 2.70%

RVLP -32.05%

RVMD -0.93%

RVMDW -30.00%

RVNC 0.21%

RVPH -1.98%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.37%

RYTM -5.88%

RYZB 0.02%

RZLT 3.87%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -3.60%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.30%

SCPS 0.00%

SEEL -8.18%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.38%

SGMT -2.47%

SGTX -2.56%

SIOX 22.63%

SLDB -8.97%

SLGL 4.12%

SLN -4.57%

SLNO -4.44%

SLRX 5.26%

SLS -1.71%

SMMT -1.75%

SNDX 1.23%

SNGX -4.91%

SNPX -4.44%

SONN 0.00%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.04%

SRRA 0.00%

SRRK -2.23%

SRZN -2.45%

STAB 0.00%

STOK -5.52%

STRO -3.67%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -7.49%

SWTX -0.33%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.62%

TARS 0.19%

TBPH 0.48%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.05%

TECH -0.22%

TENX 1.91%

TERN -8.28%

TFFP -5.33%

TGTX -4.45%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.66%

TNXP -6.00%

TNYA -4.72%

TPST 4.86%

TRDA -4.06%

TRVI 2.30%

TRVN 1.60%

TSHA -22.87%

TSVT -3.33%

TTNP -7.66%

TVTX 1.26%

TYRA -8.53%

UBX -2.83%

UNCY -4.00%

URGN -1.15%

UTHR 0.55%

VACC 11.36%

VALN -4.07%

VAXX 100.00%

VBIV 0.33%

VBLT -8.77%

VCEL 0.96%

VCNX 10.35%

VCYT -1.45%

VERA -4.07%

VERU 0.98%

VERV -2.96%

VIGL 4.84%

VINC 2.28%

VIR 0.98%

VIRI -1.73%

VIRX 3.15%

VKTX -1.33%

VLON -13.04%

VNDA -3.52%

VOR -1.62%

VRCA 0.00%

VRDN -4.39%

VRNA -0.40%

VRPX 0.38%

VRTX 0.30%

VSTM -0.85%

VTGN -1.79%

VTVT -2.97%

VTYX -1.05%

VXRT -5.10%

VYGR -0.13%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.18%

XBIO 1.03%

XBIT -2.09%

XCUR 3.55%

XENE -1.35%

XERS 2.62%

XFOR 4.67%

XLO 3.94%

XLRN 0.00%

XNCR 0.52%

XOMA -3.34%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.59%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-17	Oyler John	Sell	297	American Depositary Shares
2024-06-17	Oyler John	Sell	608	American Depositary Shares
2024-06-17	Oyler John	Sell	376	American Depositary Shares
2024-06-17	Wang Julia Aijun	Sell	154	American Depositary Shares
2024-06-17	Wang Julia Aijun	Sell	195	American Depositary Shares

INSIDER POWER
58.60
Last 99 transactions
Buy: 4 515 134 \| Sell: 1 554 871

相关性 (AI algo v.1.1b): Undervalued: 0.09% $146.93 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.58 (weak)

短: 0.92 (very strong)

Signal:(45.823) Expect same movement, but be aware

BeiGene Ltd. 相关性

10 最正相关
OZEM	1
DFAPX	0.863
MZCSX	0.863
MZCIX	0.856
ICMBX	0.855
DODIX	0.848
ETNRX	0.848
BGFLX	0.844
GSHIX	0.843
DODLX	0.84

10 最负相关
CCSB	-0.887
GECCI	-0.866
NEWZ	-0.864
BOTT	-0.834

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

BeiGene Ltd. 相关性 - 货币/商品

-0.51
( weak negative )

-0.69
( moderate negative )

0.70
( moderate )

-0.53
( weak negative )

-0.56
( weak negative )

0.60
( weak )

BeiGene Ltd. 财务报表

Annual	2023
营收:	$2.46B
毛利润:	$1.99B (81.13 %)
EPS:	$-8.45

FY	2023
营收:	$2.46B
毛利润:	$1.99B (81.13 %)
EPS:	$-8.45

FY	2022
营收:	$1.42B
毛利润:	$-511.06M (-36.09 %)
EPS:	$-19.43

FY	2021
营收:	$1.18B
毛利润:	$-447.86M (-38.07 %)
EPS:	$-16.93

Financial Reports:

No articles found.

BeiGene Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BeiGene Ltd.

BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.